Skip to main content

Table 1 Characteristics of patients and their MGMT promoter methylation status determined by HRM, MSP, and PSQ in 83 malignant gliomas, including 18 IDH1-mutated cases

From: MGMT promoter methylation determined by HRM in comparison to MSP and pyrosequencing for predicting high-grade glioma response

Characteristics n HRM me (%) MSP me (%) PSQ me (%) IDH1 mut (%)
All patients 83 51.8 37.3 54.2 21.7
Woman 28 50.0 39.3 53.6 21.4
Man 55 52.7 36.4 54.5 21.8
Age ≥70 27 44.4 25.9 44.4 0.0
Age <70 56 55.4 42.9 58.9 32.1
Grade III 23 73.9 56.5 69.6 69.6
Grade IV 60 43.3 30.0 48.3 3.3
\